Clinical Authority Readiness
SCRIMED prepares every hard clinical authority gate without pretending those gates are cleared.
This layer organizes live-care authority, PHI processing, legal approval, regional regulatory approval, reimbursement review, security certification, connector acceptance, and production clinical authorization into explicit evidence packs, retained gates, safe workarounds, and next operator actions.
Hard boundary
Preparation is active. Authorization remains blocked until signed evidence exists.
SCRIMED Clinical Authority Readiness prepares the company for live clinical care authority, PHI processing, legal approval, regional regulatory approval, reimbursement review, security certification, and production clinical authorization. It does not grant any of those authorities. SCRIMED remains synthetic-only and review-gated until signed customer scope, qualified counsel review, privacy/security approval, licensed clinical governance, reimbursement policy review, security certification evidence, regional approval, connector validation, incident response, rollback, monitoring, and explicit go-live approval are complete.
01Keep all current buyer demos, public APIs, and pilot workflows synthetic-only or metadata-only.
02Use this readiness layer as the front door for hard-gate discussions with buyers, counsel, security, clinical governance, and reimbursement reviewers.
03Select one narrow intended use and care setting before any regulatory or clinical approval discussion.
04Prepare BAA/DPA, data-flow, risk-analysis, and safeguard mapping before any PHI request is accepted.
05Collect external approval evidence as protected metadata links, not sensitive documents, until the storage authority path is signed.
06Require signed release authority before any public claim, security certification claim, regional launch claim, reimbursement claim, or production clinical go-live.
Authority domains
Every known hard gate has an owner, evidence path, retained gate, and safe workaround.
blocked-before-approval
Live clinical care authority
SCRIMED may demonstrate synthetic workflow intelligence and readiness planning, but it may not deliver care, triage emergencies, diagnose, treat, prescribe, order, or communicate patient instructions.
Clinical-care gates, Trust Cards, blocked capability lists, human-review controls, and protected clinical activation dossiers are available for review.
- Gate: No patient-impacting workflow until licensed clinical sign-off and customer go-live approval are recorded.
- Workaround: Sell synthetic pilot evaluation, workflow intelligence assessment, and draft-only clinician-reviewed planning.
- Owners: Clinical governance, Product, Legal, Customer clinical sponsor
- Proof: /clinical-care-activation, /pilot-workspace/access, /trust-os
customer-specific-required
PHI and ePHI processing authority
Public routes, demos, smoke checks, and readiness packets remain synthetic-only or metadata-only. No live patient identifiers, payer member records, or production clinical records are authorized.
Protected workspaces, AAL2 gates, audit logs, evidence-room metadata controls, provider security review, and procurement evidence registry are in place.
- Gate: No PHI, ePHI, patient record, payer member data, or production credential enters SCRIMED until legal and privacy/security authorization is signed.
- Workaround: Use synthetic fixtures, de-identified data only when contract-approved, and no-sensitive-artifact evidence links.
- Owners: Privacy, Security, Legal, Customer compliance
- Proof: /trust-center, /public-market-readiness, /pilot-workspace/access
customer-specific-required
Legal approval and contracting authority
SCRIMED materials can describe readiness, pilots, and retained gates. They are not legal advice, executed contracting authority, certification, or production authorization.
Approved/prohibited claim controls, release decisions, named reviewer sign-offs, distribution lockbox, release authority attestations, and external approval evidence links are active.
- Gate: No public customer claim, live care claim, certified compliance claim, or production deployment claim without qualified release approval.
- Workaround: Use controlled buyer packets with explicit boundaries and no public customer or certification claims.
- Owners: Legal, Sales, Founder, Customer executive sponsor
- Proof: /trust-center, /public-market-readiness, /global-reach
external-approval-required
Regional regulatory approval
Global Reach maps priority regions and localization requirements, but it does not create regional legal, procurement, privacy, data-residency, or clinical authorization.
Region packs, deployment profiles, sovereign-readiness posture, localization questions, and retained approval gates are organized.
- Gate: No production regional launch, government program claim, or local clinical deployment claim until the region-specific authority path is approved.
- Workaround: Run synthetic executive evaluations and partner qualification without live data, public authority claims, or production integrations.
- Owners: Regional counsel, Global partnerships, Security, Customer sponsor
- Proof: /global-reach, /deployment-profiles, /market-activation
customer-specific-required
Reimbursement, coverage, coding, and payer policy approval
SCRIMED can support draft operational intelligence for prior authorization, denial risk, and revenue-cycle review, but it cannot guarantee reimbursement or submit claims without authorized human review.
Finance methodology gates, KPI definitions, no-guarantee language, protected metric rollups, and public-market operating discipline are available.
- Gate: No coverage determination, final coding, claim submission, denial appeal submission, or reimbursement claim without qualified review.
- Workaround: Deliver denial-risk review, prior-authorization packet drafting, and revenue leakage analysis as human-reviewed draft support.
- Owners: Revenue cycle, Finance, Legal, Customer operations
- Proof: /public-market-readiness, /pricing, /pilot-deal-room
external-approval-required
Security certification and procurement approval
SCRIMED has security-ready architecture evidence and protected review workflows, but it does not claim SOC 2, ISO, HITRUST, FedRAMP, penetration-test approval, or customer vendor-risk approval unless those artifacts are actually issued.
Provider security review, procurement evidence registry, access-log reconciliation, Trust Safety Ops, incident workspaces, and audit packets are active.
- Gate: No security certification, procurement approval, or production security acceptance claim without issued evidence and customer acceptance.
- Workaround: Present readiness posture, control inventory, and no-sensitive-artifact evidence links while independent certification remains pending.
- Owners: Security, Procurement, Compliance, Customer vendor-risk team
- Proof: /trust-safety-operations, /public-market-readiness, /pilot-workspace/access
blocked-before-approval
Production clinical authorization
Production clinical execution is denied. No live workflow may write records, message patients, submit payer transactions, or affect clinical operations without final authorization.
Customer activation approvals, production SSO readiness, buyer diligence room, command intelligence packets, and clinical activation approval workflow are linked.
- Gate: No production tenant go-live until customer, clinical, legal, privacy, security, support, and SCRIMED release authority sign off.
- Workaround: Use protected pilot rooms, command snapshots, and readiness packets to prepare the go-live decision without activating production care.
- Owners: Operations, Security, Clinical governance, Customer executive sponsor
- Proof: /pilot-workspace/access, /clinical-care-activation, /operations
external-approval-required
Certified health IT and connector approval
SCRIMED can demonstrate synthetic FHIR, HL7, DICOM, X12, and EHR-readiness concepts, but it does not claim ONC certification, EHR marketplace approval, payer connection approval, or live connector certification.
Interoperability standards registry, synthetic conformance kits, integration contracts, and deployment profile evidence are active.
- Gate: No production connector read, write, order, referral, claim, imaging retrieval, or record mutation until customer and platform approval are complete.
- Workaround: Use synthetic conformance tests, fixture validation, and connector contracts with live connector actions denied.
- Owners: Interoperability, Security, Customer integration, Platform partner
- Proof: /interoperability, /interoperability/evaluations, /integrations/fixture-validation
Boundary resolution
Known limitations are contained with workarounds while signed approvals remain mandatory.
contained-with-workaround
Live clinical care authority
Unauthorized patient-impacting use, clinical harm, regulatory exposure, and buyer trust failure.
Keep live care blocked and require intended-use review, licensed governance, safety case, validation protocol, and signed go-live approval.
Licensed clinical sign-off and customer release decision.
contained-with-workaround
PHI processing
Unauthorized PHI exposure, privacy breach, contract breach, and security liability.
Keep PHI disabled; use synthetic data, metadata-only evidence links, BAA/DPA path, data-flow approval, and safeguard mapping.
Signed BAA/DPA or non-PHI determination plus security acceptance.
contained-with-workaround
Legal approval
Unapproved claims, scope mismatch, public misrepresentation, and contract exposure.
Route claims, PR, case studies, public releases, and customer-specific statements through protected release authority workflows.
Qualified legal and release-authority approval.
contained-with-workaround
Regional regulatory approval
Improper regional deployment, data-residency violations, procurement failure, or invalid public-sector claims.
Use Global Reach for localization and regional readiness while requiring counsel, residency, procurement, and partner validation.
Region-specific counsel and customer/procurement acceptance.
contained-with-workaround
Reimbursement certainty
Improper billing, false buyer expectations, payer disputes, and compliance risk.
Keep reimbursement outputs draft-only and human-reviewed with no-guarantee language and policy-specific review.
Revenue-cycle, legal, payer-policy, and customer approval.
contained-with-workaround
Security certification
False certification claims, procurement failure, and customer security rejection.
Present readiness controls, evidence references, and gap mapping; do not claim SOC 2, ISO, HITRUST, FedRAMP, or pentest approval without issued evidence.
Issued artifact, scoped assessment, and customer vendor-risk acceptance.
contained-with-workaround
Production clinical authorization
Unsafe go-live, record mutation errors, unsupported incidents, and uncontrolled rollout.
Require final release decision, production SSO/RBAC, connector acceptance, monitoring, rollback, incident response, and post-launch review.
All-domain go-live packet signed by SCRIMED and customer owners.
Preparation workstreams
SCRIMED can keep moving without accepting PHI or live clinical execution prematurely.
workstream
Authority evidence packet
Bundle clinical, PHI, legal, regional, reimbursement, security, connector, and production gates into one buyer-reviewable authority packet.
Use the protected workspace to collect metadata-only evidence links and reviewer status, not sensitive artifacts.
- Current evidence: Clinical Activation Dossier, Protected External Approval Evidence, Protected Procurement Evidence Registry, Protected Provider Security Reviews
- Missing before clearance: Actual signed approvals, Customer-specific scope, Qualified external review, Issued certification artifacts where applicable
workstream
PHI processing launch track
Prepare the minimum path for legally authorized ePHI handling without enabling PHI by default.
Keep PHI disabled and create customer-specific data-flow diagrams during sales engineering.
- Current evidence: AAL2 protected actions, Tenant-scoped audit events, No-sensitive-artifact evidence-room posture, Synthetic-only smoke checks
- Missing before clearance: BAA/DPA or non-PHI determination, Risk analysis and safeguard map, Data retention and deletion approval, Customer security acceptance
workstream
Clinical safety and governance track
Convert clinical ambition into reviewer assignments, safety case evidence, and human authority controls.
Recruit qualified clinical governance and lock a narrow intended-use statement before any patient-specific pilot.
- Current evidence: Blocked clinical capability list, Trust Cards, Clinical activation gates, Named reviewer sign-off workflow
- Missing before clearance: Licensed medical director, Clinical safety board charter, Prospective validation protocol, Emergency and adverse-event escalation policy
workstream
Security certification and procurement track
Prepare certification and vendor-risk evidence without claiming certification before independent evidence exists.
Run a control-gap assessment and map current evidence to target frameworks before starting an audit.
- Current evidence: Provider security review workbench, Procurement evidence registry, Evidence-room access log reconciliation, Trust Safety Operations
- Missing before clearance: External audit scope, Control test evidence, Penetration-test evidence if required, Customer vendor-risk acceptance
Evidence packs
Authority readiness routes connect public review to protected no-PHI diligence packets.
pack
Protected clinical authority evidence room
AAL2-protected no-PHI control plane that assembles reviewer owners, evidence links, expiration posture, retained gates, and audit history across every clinical authority hard gate.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/clinical-authority-evidence-room/packet
Protected metadata-only authority readiness; not clinical, legal, PHI, reimbursement, security, regional, connector, or production approval.
pack
Protected clinical authority owner matrix
AAL2-protected no-PHI owner routing matrix that maps every hard gate to customer, SCRIMED, and qualified external approver roles before authority review.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/clinical-authority-owner-matrix/packet
Protected owner labels and routing metadata only; not signed approval, authority, legal advice, certification, reimbursement certainty, or live clinical authorization.
pack
Protected clinical authority artifact intake checklist
AAL2-protected no-PHI checklist that maps authority owner assignments to required external systems of record, qualified reviewer roles, validation timestamps, expiration cadences, prohibited content, and acceptance criteria before any signed authority review.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/clinical-authority-artifact-intake/packet
Protected metadata references only; not artifact upload, signed approval, PHI processing, legal advice, certification, reimbursement certainty, production authorization, or live clinical authorization.
pack
Protected authority artifact references
AAL2-protected no-PHI status capture for externally retained authority artifacts with reviewer labels, validation timestamps, expiration dates, renewal alerts, and metadata-only reference IDs.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/authority-artifact-references/packet
External references only; not artifact storage, URL storage, signed approval, PHI processing, legal advice, certification, reimbursement certainty, production authorization, public distribution, or live clinical authorization.
pack
Protected authority renewal queue and QA harness
AAL2-protected no-PHI renewal queue and authenticated synthetic QA path for missing, pending, due, expired, or rejected authority references.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/authority-artifact-references/renewal-queue
Operational readiness and QA verification only; not clinical, legal, security, reimbursement, regional, connector, production, distribution, or live-care authority.
pack
Clinical activation dossier
Tenant-scoped no-PHI evidence packet for clinical go-live planning, reviewer assignments, unsigned approvals, and blocked capabilities.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/clinical-activation-dossier/packet
AAL2-protected and no-PHI; not live clinical authorization.
pack
External approval evidence
Protected metadata-only evidence links for counsel, certification, buyer, clinical, security, and finance approval artifacts.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/external-approval-evidence/packet
Stores evidence references and reviewer status, not sensitive source artifacts.
pack
Provider security review
Security and procurement readiness workbench for vendor-risk review, control evidence, and customer security questions.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/provider-security-reviews/packet
Readiness evidence only; not security certification.
pack
Procurement evidence registry
Metadata-only registry for SOC, ISO, HITRUST, pentest, legal, privacy, and procurement artifacts before buyer review.
Open pack route
/api/pilot-workspaces/{workspaceSlug}/procurement-evidence/packet
No sensitive artifact storage and no certification claim.
pack
Clinical authority readiness brief
Public executive brief summarizing hard gates, safe workarounds, source references, and next operator actions.
Open pack route
/api/clinical-authority-readiness/brief
Public readiness summary; not legal advice or production authorization.
Operating modes
Only synthetic evaluation is permitted now; every higher-risk mode has explicit entry criteria.
permitted-now
Governed synthetic evaluation
Use this as the default sellable pilot and enterprise evaluation motion.
Entry criteria
- Synthetic fixtures only
- Human review required
- No patient identifiers
- No production connectors
- Blocked until: None for current product boundary
blocked-now
De-identified or customer-approved shadow evaluation
Prepare the packet now, but do not ingest data until the determination and scope are signed.
Entry criteria
- Written non-PHI or approved de-identification determination
- Customer data-flow approval
- Security and privacy review
- Reviewer rubric
- Blocked until: Customer-specific legal approval, Privacy/security acceptance, Validation protocol approval
blocked-now
Clinician-supervised prospective pilot
Keep all outputs draft-only and human-reviewed; no autonomous clinical action.
Entry criteria
- Licensed clinical governance
- Clinical safety case
- Incident response and rollback
- Customer go-live approval
- Blocked until: Regulatory classification review, Clinical protocol approval, PHI and connector authorization where applicable
blocked-now
Production clinical execution
Do not activate until every retained gate has an accountable signed approval record.
Entry criteria
- All authority domains cleared
- Signed release decision
- Monitoring and shutdown authority
- Post-launch review cadence
- Blocked until: Customer, legal, privacy, security, clinical, reimbursement, regional, connector, and operational approvals
Source references
Authority readiness is anchored to official references and SCRIMED internal controls.
official-government
HHS HIPAA Security Rule Summary
PHI/ePHI readiness must include administrative, physical, and technical safeguards, risk analysis, access review, and incident detection before production processing.
Source checked 2026-06-20official-government
HHS Business Associate Contracts
A BAA path or non-PHI determination is a retained gate before SCRIMED can receive, maintain, transmit, or create PHI for a covered entity or business associate workflow.
Source checked 2026-06-20official-government
FDA Clinical Decision Support Software Guidance
Intended use, clinical claims, user role, output transparency, and medical-device boundaries must be reviewed before patient-specific clinical decision support claims.
Source checked 2026-06-20official-government
ONC Health IT Certification Program
Connector, certified-health-IT, and interoperability claims require conformance evidence and appropriate certification, marketplace, or customer acceptance where applicable.
Source checked 2026-06-20official-government
NIST Cybersecurity Framework 2.0
Security certification preparation should map governance, identification, protection, detection, response, and recovery evidence before procurement or production claims.
Source checked 2026-06-20official-government
CMS Medicare Coverage Determination Process
Reimbursement and coverage claims must remain workflow-specific and policy-reviewed; SCRIMED should not guarantee coverage, payment, coding, or claim outcomes.
Source checked 2026-06-20internal-control
SCRIMED protected workspace, TrustOS, and clinical activation controls
Current product evidence supports synthetic pilot diligence, human review, auditability, protected packets, and retained gates, not live clinical authorization.
Internal control checked 2026-06-20